Concepedia

Author

I. Shchepotin

National Cancer Institute

Also Known As

I B Shchepotin, I Shchepotin, I. B Shchepotin, I. B. Schepotin, I. B. Shchepotin, I. Shchepotin, I.B. Shchepotin, I.B. shchepotin, Igor B Shchepotin, Igor B. Shchepotin

100

Publications

3.2K

Citations

19

H-Index

56

Concepts

All Affiliations

National Cancer InstituteGeorgetown UniversityGeorgetown University Medical CenterUniversity of California, IrvineGeorge Washington University
IS

About

I. Shchepotin is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

919

2

Public Health

2

2

77

3

Cell Biology

2

2

87

4

Engineering

1

1

98

5

Health Sciences

1

1

314

I. Shchepotin

×

23

Publications

3.1K

Citations

19

H-Index

YearCitations

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor <i>KRAS</i> and <i>BRAF</i> Mutation Status

Eric Van Cutsem, Claus-Henning Köhne, István Láng,

Journal of Clinical Oncology

2011

1.9K

Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial

Eric Van Cutsem, Marek P. Nowacki, István Láng,

Journal of Clinical Oncology

2007

314

Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin

A. V. Shevchenko, Andriy Romanov, M. Tselepi,

Nanomedicine Nanotechnology Biology and Medicine

2014

98

Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer.

Stephen R.T. Evans, Jose M. Nolla, John Hanfelt,

PubMed

1998

91

Extended surgical resection in T4 gastric cancer

I. Shchepotin, Vyacheslav A. Chorny, Russell J. Nauta,

The American Journal of Surgery

1998

83

Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma

I. Shchepotin, Stephen R.T. Evans, Viacheslav Chorny,

Surgical Oncology

1994

68

Cetuximab plus FOLFIRI: Final data from the CRYSTAL study on the association of <i>KRAS</i> and <i>BRAF</i> biomarker status with treatment outcome.

Eric Van Cutsem, István Láng, Gunnar Folprecht,

Journal of Clinical Oncology

2010

61

Mechanisms of tumor-promoting activities of nicotine in lung cancer: synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors

Alex I. Chernyavsky, I. Shchepotin, Valentin Galitovkiy,

BMC Cancer

2015

60

1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model.

Stephen R.T. Evans, E I Shchepotin, Heather A. Young,

International Journal of Oncology

2000

50

Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors

Alex I. Chernyavsky, I. Shchepotin, Sergei A. Grando

International Immunopharmacology

2015

49

Page 1